Celltrion Pharm, Active Community... Stock Price Up 1.57%.
At this time, posts about Celltrion Pharm are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 47,000 shares of Celltrion Pharm, while institutions have sold a net 3,000 shares. Celltrion Pharm is known as a company specializing in pharmaceuticals and health supplements.
As of 11:30 AM on the 12th, the stock price of Celltrion Pharm is 135,800 KRW, up 1.57% from the previous day, with a trading volume of 1,611,423 shares, which is 74.27% of the 5-day average trading volume. On June 3rd, Celltrion Pharm became an issue in the market for two consecutive days with news about 'Insulin injection development and COVID-19 treatment experiment results...'.
In addition to Celltrion Pharm, posts by investors are also rapidly increasing regarding Samsung Electro-Mechanics Preferred (009155), Hanwha Preferred (000885), and Hanwha Solutions Preferred (009835).
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Man in His 40s Who Kept Girlfriend's Body for a Year After Murder Sentenced to 30 Years in Prison Again on Appeal
- Despite Captivating the Nation for Over a Month... "Timmy" the Whale Ultimately Found Dead
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
